Close Menu

NEW YORK (360Dx) – British diagnostics firm Oncimmune said today that it has made SmartGene the exclusive distributor of its EarlyCDT-Lung test in Poland.

Oncimmune's test measures levels of seven autoantibodies in patient blood to aid in the early detection of lung cancer. The company markets EarlyCDT-Lung both for detecting lung cancer before it can be picked up via imaging techniques and for helping to evaluate whether nodules detected via imaging are likely malignant or benign.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.